American Cancer Society
Evolution of cancer treatments: Chemotherapy
Accessed 4/10/15

Baquiran, D.C. (2001). Cancer Chemotherapy Handbook. (2nd Ed. ) Philadelphia: Lippincott. 85-140.

Barr S, Thomson S, Buck E, et al. (2008)
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions.
Clinical & Experimental Metastasis. 2008;25:685–693

Bartlett, D; Liu, Z; Sathaiah, M; et al (2013)
Oncolytic viruses as therapeutic cancer vaccines.
Molecular Cancer 2013, 12:103 

Bender, C.B. In: Itano, J.K., & Taoka, K.N. (1998). Cancer chemotherapy agents. In: Itano, J.K., & Taoka, K.N. (1998). Core Curriculum in Oncology Nursing, 3rd Ed. Philadelphia: W.B. Saunders, 641-655.

Blagosklonny, M; Pardee, A. (2000)
The Restriction Point of the Cell Cycle
Madame Curie Bioscience Database [Internet]
Austin (TX): Landes Bioscience

Canadian Association of Nurses in Oncology
National Strategy for Chemotherapy Administration
Accessed online 4/10/15

Cancer Management: A Multidisciplinary Approach: Medical, Surgical, & Radiation Oncology 7th Ed.Richard Pazdur, MD, Lawrence R. Coia, MD, William J. Hoskins, MD, and Lawrence D. Wagman, MD, FACS
SCP Oncology Group
Published 06/15/2003

Cancer multidrug resistance
Nature Biotechnology 18, IT18 - IT20 (2000)

Cancer Research UK
Mustard gas – from the Great War to frontline chemotherapy.
Accessed online 4/11/15

Centers for Disease Control and Prevention
Workplace Safety & Health Topics
Accessed online 3/12/15

Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH)
Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings (2004)
Accessed online 3/12/15

Christman, J. (2002)
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
Oncogene. 12 August 2002, Volume 21, Number 35, Pages 5483-5495

Dear. F; McGeechan K; Jenkins MC, et al. (2013)
Combination versus sequential single agent chemotherapy for metastatic breast cancer.
Editorial Group: Cochrane Breast Cancer Group
Published Online: 18 DEC 2013

Center for Disease Control and Prevention
National Institute for Occupational Safety and Health
DHHS (NIOSH) Publication Number 2004−165

Accessed online 5/30/2015

Growenwald, S, et al. (1995). Comprehensive Cancer Nursing Review, (2nd ed). Boston: Jones and Barlett, 118-125.
Guy, J.L., & Ingram, B.A. (1996). Medical oncology: The agents. In: R. Mc Corkcle, et al. (Eds). Cancer Nursing: A Comprehensive Textbook. Philadelaphia: W.B. Saunders, 359-394.

Heine, G; Drozdenko, G; Grün, JR; Chang, HD; Radbruch, A; Worm, M.
Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts.
European Journal of Immunology. 2014 Jun;44(6):1615-21.

Henderson, B. and Feigelson, H. (2000)
Hormonal carcinogenesis
Carcinogenesis (2000) 21 (3): 427-433.
Oxford University Press

Hochhauser, D
Cancer and its Management
John Wiley & Sons, Oct 3, 2014

Housman, G; Byler, S; Heerboth, S; et al. (2014)
Drug Resistance in Cancer: An Overview
Cancers 2014, 6, 1769-1792

Huber, R; Lucas, J; Gomez-Sarosi, L.; et al. (2014)
DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate ;cancer treatment resistance.
Oncotarget, Advance Publications December 10, 2014

Kiess W, Gallaher B.
Hormonal control of programmed cell death/apoptosis.
European Journal of Endocrinology 1998 May;138(5):482-91.

Kim HJ, Litzenburger BC, Cui X, et al. (2007).
Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail.
Molecular & Cellular Biology. 2007;27:3165–3175

Kuske, B; Naughton, C; Moore, K; et al. (2006)
Endocrine therapy resistance can be associated with high estrogen receptor a (ERa) expression and reduced ERa phosphorylation in breast cancer models.
Endocrine-Related Cancer (2006) 13 1121–1133

Maxon, J.H., & Wolk, J.E. (1998). Principles of preparation, administration, and disposal of antineoplastic agents. In: Itano, J.K., & Taoka, K.N. Core Curriculum in Oncology Nursing, 3rd Ed., Philadelphia: W.B. Saunders, 657-660

Miller, D.R. (2006)
A tribute to Sidney Farber – the father of modern chemotherapy
British Journal of Haematology, 134, 20–26

Mini, E; Nobili, S; Caciagli, B; Landini, I; Mazzei, T.
Cellular pharmacology of gemcitabine
Annals of Oncology 17 (Supplement 5): v7–v12, 2006

NCCN Task Force Report: Oral Chemotherapy
Journal of the National Comprehensive Cancer Network, Volume 6, Supplement 3, March 2008

NIH National Cancer Institute
Biological Therapies for Cancer.

NIOSH Study Finds Lack of Adherence to Safe Handling Guidelines for Administration of Antineoplastic Drugs.
NIOSH Update: September 26, 2014

Personal Protective Equipment for Health Care Workers Who Work with Hazardous Drugs
Accessed online 4/9/15

Ohba, T; Cates, J; Cole, H; Slosky, D; et al.
Autocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma
Molecular Cancer Research
August 2014 12; 1100

Otto, K; Vander Griend, D; Conzen,S; Szmulewitz, R. (2015)
Abstract 148: Glucocorticoid receptor-mediated cell survival following androgen receptor blockade in castrate-resistant prostate cancer.
Proceedings: AACR 103rd Annual Meeting 2012-- Mar 31-Apr 4, 2012; Chicago, IL
Journal of Cancer Research April 15, 2012 72;

Parker, W (2009)
Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer.
Chemical Reviews. 2009 Jul; 109(7): 2880–2893.

Robertson J, Blamey R. (2003)
The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women.
European Journal of Cancer. 2003 May;39(7):861-9

Schwab, M.
Encyclopedia of Cancer, Volume 1
Springer Science & Business Media, Sep 23, 2011

Shanie, E; Xu, W. (2010)
Selectively targeting estrogen receptors for cancer treatment.
Advanced drug delivery reviews. 2010;62(13):1265-1276

Shohara, R; Yamamoto, A; Takikawa, S; et al. (2012)
Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.
Cytotherapy 2012 Nov;14(10):1171-81

Swift, L; Golsteyn, R. (2014)
Genotoxic Anti-Cancer Agents and Their Relationship to DNA Damage, Mitosis, and Checkpoint Adaptation in Proliferating Cancer Cells .
International Journal of Molecular Sciences 2014, 15, 3403-3431

Thompson, E; Johnson, B. (2003)
Regulation of a Distinctive Set of Genes in Glucocorticoid-evoked Apoptosis in CEM Human Lymphoid Cells
The Endocrine Society
Accessed 6/22/15

University of California - Davis
Anti-Cancer Drugs II
Accessed online 5/26/15

U.S. Food and Drug Administration
Prescribing information for SOMATULINE® DEPOT (lanreotide) INJECTION.

Walsh, J; Karnes, W; Cuttitta, F; Walker, A.
Autocrine growth factors and solid tumor malignancy.
Western Journal of Medicine. 1991 Aug; 155(2): 152–163.

Yemelyanov, A; Czwornog, J; Chebotaev, D; etc. (2007)
Tumor suppressor activity of glucocorticoid receptor in the prostate.
Oncogene (2007) 26, 1885–1896.